Papillary thyroid microcarcinoma with and without nodal metastasis: A comparative analysis

Saleh Alqaryan1, Hisham Almousa1, Raed Almutairi1

  • 1From the Otolaryngology - Head and Neck Surgery Department (Alqaryan, Almousa, Alessa, Aldhahri, Alqahtani), King Saud University; from the Otolaryngology - Head and Neck Surgery Division, Department of Surgery (Alqaryan), King Abdulaziz Medical City, National Guard for Health Affairs; from the Otolaryngology - Head and Neck Surgery Department (Almayouf, Albarrak), King Fahad Medical City; from the Otolaryngology - Head and Neck Surgery Department (Doubi), King Saud Medical City; from the Otolaryngology - Head and Neck Surgery Department (Altuwaijri), Security Forces Hospital; from the College of Medicine (Alqahtani), Imam Mohammad Ibn Saud Islamic University, Riyadh; and from the Otolaryngology - Head and Neck Surgery Department (Almutairi), King Fahad Specialist Hospital, Buraidah, Kingdom of Saudi Arabia.

Saudi Medical Journal
|March 4, 2024
PubMed
Summary

Papillary thyroid microcarcinoma (PTMC) in Saudi Arabia shows a 9.17% lymph node metastasis (LNM) rate. Key risk factors for LNM include higher Bethesda class and extrathyroidal extension, informing clinical risk assessment.